What is the recommended piperacillin‑tazobactam dosing regimen for an adult on intermittent hemodialysis (including guidance for CRRT and peritoneal dialysis)?

Piperacillin-Tazobactam Dosing in Dialysis

For intermittent hemodialysis, administer piperacillin-tazobactam 2.25 g every 8 hours as a 3–4 hour extended infusion, given immediately after each dialysis session on dialysis days. 1

Intermittent Hemodialysis (IHD) Dosing

Loading Dose Strategy

• Give a full 4.5 g loading dose regardless of renal function, infused over 3–4 hours, to rapidly achieve therapeutic concentrations in the expanded extracellular volume from fluid resuscitation. 1
• Loading doses are never adjusted for renal impairment—only maintenance dosing requires modification. 1

Maintenance Dosing Regimen

• Administer 2.25 g every 8 hours by extended infusion (3–4 hours) for patients with creatinine clearance <20 mL/min not yet on dialysis. 1
• On dialysis days, give the dose immediately after the dialysis session to prevent premature drug removal and ensure adequate therapeutic levels throughout the 48–72 hour interdialytic interval. 2
• For thrice-weekly hemodialysis schedules, this translates to dosing three times per week post-dialysis. 2

Critical Infusion Duration

• Never use standard 30-minute infusions in dialysis patients—always infuse over 3–4 hours to maximize time above MIC and improve clinical outcomes. 1
• Meta-analyses demonstrate that extended infusion reduces mortality (RR 0.70; 95% CI 0.56–0.87) compared to intermittent bolus dosing in critically ill patients. 1

Post-Dialysis Supplementation

• Hemodialysis removes 30–40% of piperacillin during a 4-hour session. 3
• Administer a supplemental 0.75 g dose after each hemodialysis session to replace drug removed during dialysis. 3

Continuous Renal Replacement Therapy (CRRT)

Standard CRRT Dosing

• For CRRT with effluent rates of 25–35 mL/kg/h, administer 12 g/day (4.5 g every 8 hours or 3 g every 6 hours) as extended infusions. 4
• Patients with residual creatinine clearance >50 mL/min may have five-fold higher clearance compared to those with CrCl <10 mL/min, even while on CRRT. 1

Therapeutic Drug Monitoring on CRRT

• Obtain plasma piperacillin concentrations 24–48 hours after therapy initiation due to significant pharmacokinetic variability during CRRT. 1
• Target trough piperacillin concentration of 33–64 mg/L for optimal outcomes. 1
• Concentrations >157 mg/L predict neurotoxicity with 97% specificity—adjust dosing if levels exceed this threshold. 1

CRRT Modality Differences

• During CVVH at 1 L/h, piperacillin clearance is 3.89 L/h with 29% eliminated in 12 hours. 3
• During CVVHDF at 2 L/h, clearance increases to 5.48 L/h with 46% eliminated in 12 hours. 3
• For CVVH or CVVHDF at 1–2 L/h, dose 4 g/0.5 g every 8 hours. 3

Peritoneal Dialysis

Intraperitoneal Administration

• Give a loading dose of 4 g/0.5 g intraperitoneally, which achieves plasma concentrations of 51.6 mg/L at 1.5 hours—comparable to intravenous administration. 5
• For maintenance, administer 0.5 g/0.0625 g with each dialysate exchange, though this dose should be augmented for severe infections. 5
• Tazobactam is poorly absorbed from peritoneal dialysate (detected in only 1 of 6 patients), limiting the utility of intraperitoneal administration for systemic infections. 5

Therapeutic Drug Monitoring (TDM)

When to Obtain Levels

• Measure trough concentrations 24–48 hours after starting therapy in all dialysis patients. 1
• Repeat TDM after any dosage change or with significant clinical deterioration. 1
• Daily creatinine monitoring is essential as renal function can fluctuate rapidly in critically ill patients. 1

Target Concentrations

• Target trough: 33–64 mg/L for optimal clinical outcomes and lowest mortality. 1
• Neurotoxicity threshold: >157 mg/L—reduce dose if levels exceed this. 1
• For severe Pseudomonas infections, aim for 100% fT>4×MIC, which may require continuous infusion with increased daily dose. 1

Common Pitfalls to Avoid

• Do not reduce the loading dose based on renal impairment—this delays therapeutic attainment and worsens outcomes. 1
• Do not administer antibiotics before dialysis—this results in subtherapeutic levels and treatment failure. 2
• Do not use 30-minute infusions—this fails to maintain adequate concentrations throughout the dosing interval. 1
• Do not underdose at 3.375 g every 6 hours for sepsis—this lower dose is inadequate for critically ill patients, especially with Pseudomonas risk. 1